Clinical trial
High-Dose Folic Acid in Preventing Colorectal Cancer in Patients Who Have Had…
NCT00002650 · Eastern Cooperative Oncology Group, Other · Completed
Key facts
| NCT number | NCT00002650 |
|---|---|
| Title | High-Dose Folic Acid in Preventing Colorectal Cancer in Patients Who Have Had Polyps Surgically Removed |
| Official title | PHASE II DOUBLE-BLIND CHEMOPREVENTION TRIAL OF HIGH DOSE FOLIC ACID VERSUS PLACEBO IN PATIENTS WITH RESECTED COLORECTAL POLYPS |
| Lead sponsor | Eastern Cooperative Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Dietary Supplement |
| Interventions | folic acid |
| Enrollment | 80 |
| Start date | Jun 12, 1995 |
| Primary completion | Oct 17, 2004 |
| Completion | May 1, 2009 |
| First posted | Mar 11, 2004 |
| Last update posted | Jun 22, 2023 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: